My Financial Independence Journey » Archive
Thomson Reuters (TRI) Dividend Stock Analysis
Thomson Reuters (TRI) is massive publishing company. It was formed in 2008 when Thomson acquired Reuters. Currently, TRI has four business segments, Financial & Risk (56% of 2012 revenues), Legal (27%), Tax & Accounting (9%), and Intellectual Property & Science (7%). Geographically, revenues in 2011came from the Americas (58%), Europe, the Middle East and Africa (30%), and Asia (12%). In 2012, about 86% of revenues were recurring, which makes sense given that much of the information that TRI publishes … Read entire article »
Filed under: Stock Analysis
Weekend Link Love
It’s that time of the week again, isn’t it? Where I dump a handful of articles worth reading on you. Another weekend, another collection of links. Enjoy. … Read entire article »
Filed under: Link Love
Revisiting Tracking Portfolio Returns
Up to this point, I’ve written two articles detailing systems for tracking my portfolio’s returns and comparing them to the S&P500. Both of these systems had strengths and flaws. Some great feedback from commenters on the previous articles prompted me to go back, combine the best features of both systems and create what is probably the best and most accurate way to track investment returns and gauge my performance against an index. … Read entire article »
Filed under: Investment portfolio
Recent Buy – ONEOK Inc (OKE)
As part of my commitment to keep my readers up to date on my portfolio, I write up short posts describing my transactions. Recently, I purchased 26 shares of ONEOK Inc (OKE). … Read entire article »
Filed under: Investment portfolio
Teva (TEVA) Dividend Stock Analysis
Teva (Teva) is and Isreal based pharmaceutical manufacturer. It is the largest generic drug company in the world. In addition to generic drugs, Teva produces several brand name drugs including Copaxone (for multiple sclerosis) and Agilect/Azilect (for Parkinson’s disease). Generic drugs accounted for about 51% of total sales in 2012, branded drugs for 40%, and OTC medications and other revenues for 9%. 51% of sales in 2012 were in the US, 28% in Europe, and 21% came from other … Read entire article »
Filed under: Stock Analysis
Weekend Link Love
Another weekend, another collection of links. Enjoy. … Read entire article »
Filed under: Link Love
7 Reasons Everyone Should Reach Financial Independence
Why exactly would any sane person want to save 50% of their income and try to pursue financial independence? It’s a good question. I’ve written a bit about why I’m pursuing financial independence on my about page and on other posts throughout the blog, but I wanted to expand on those thoughts and discuss seven reasons why everyone should consider pursuing financial independence. … Read entire article »
Filed under: Reflections
Coca Cola (KO) Dividend Stock Analysis
Coca Cola (KO) is is the world’s largest producer of soft drink concentrates and syrups, as well as the world’s biggest producer of juice and juice-related products. Coca Cola’s products are sold in over 200 countries world wide and it owns or licenses over 500 brands. You’re probably already aware of many Coca Cola products, but did you know that they also make Fanta, Full Throttle, Sprite, Barq’s, Pibb Xtra, Mello Yello, Tab, Fresca, and Aquarius. … Read entire article »
Filed under: Stock Analysis
Weekend Link Love
Another weekend, another collection of links. Enjoy. … Read entire article »
Filed under: Uncategorized
Recent Buy – Caterpillar (CAT)
As part of my commitment to keep my readers up to date on my portfolio, I write up short posts describing my transactions. Recently, I purchased 23 shares of Caterpillar (CAT). … Read entire article »
Filed under: Investment portfolio
